The tech rout continued into Tuesday with the Nasdaq posting another loss, but the Dow and S&P 500 bounced back and had a fairly positive day. ARK Funds, along with tech in general, took another beating. ARKF performed the best out of the group, with a 0.6% loss on the day, while ARKW did the worst, down 2.5%. The gains from the past year are slowly sliding away, but Cathie Wood may have something up her sleeve, as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major purchases that ARK Invest executed on November 23, 2021. Also check out all the ARK Invest sales that took place that same day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here is a notable purchase in this fund: 313,699 shares of DraftKings, 136,697 shares of Toast, & 517,833 shares of StoneCo.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable buys in this fund: 352,967 shares of Pacific Bio, 586,994 shares of Butterfly Network, & 615,945 shares of Adaptive Bio.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 538,573 shares of Zoom Video, 282,668 shares of Invitae, & 411,502 shares of Exact Sciences.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are some notable purchases in the fund: 898,684 shares of Velo3d, 142,070 shares of Markforged, & 668,983 shares of Archer Aviation.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are some notable purchases in the fund: 106,537 shares of Zoom Video, 183,465 shares of Vuzix, 986,600 shares of Nano Dimension, & 881,741 shares of Genius Sports.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Notable trades in the fund: 51,576 shares of Palantir.
Check out all the buys here:
FUND | Direction | Ticker | Name | Shares |
---|---|---|---|---|
ARKF | Buy | DKNG | DRAFTKINGS INC | 313,699 |
ARKF | Buy | TOST | TOAST INC | 136,697 |
ARKF | Buy | STNE | STONECO LTD | 517,833 |
ARKF | Buy | HOOD | ROBINHOOD MARKETS INC | 278,355 |
ARKG | Buy | SURF | SURFACE ONCOLOGY INC | 93,013 |
ARKG | Buy | SDGR | SCHRODINGER INC/UNITED STATES | 177,712 |
ARKG | Buy | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 352,967 |
ARKG | Buy | BNR | BURNING ROCK BIOTECH LTD | 96,815 |
ARKG | Buy | BFLY | BUTTERFLY NETWORK INC | 586,994 |
ARKG | Buy | ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | 615,945 |
ARKK | Buy | ZM | ZOOM VIDEO COMMUNICATIONS INC | 538,573 |
ARKK | Buy | NVTA | INVITAE CORP | 282,668 |
ARKK | Buy | MTLS | MATERIALISE NV | 84,768 |
ARKK | Buy | EXAS | EXACT SCIENCES CORP | 411,502 |
ARKK | Buy | CRSP | CRISPR THERAPEUTICS AG | 64,595 |
ARKQ | Buy | VLD | VELO3D INC | 898,684 |
ARKQ | Buy | NIU | NIU TECHNOLOGIES | 12,917 |
ARKQ | Buy | MKFG | MARKFORGED HOLDING CORP | 142,070 |
ARKQ | Buy | ACHR | ARCHER AVIATION INC | 668,983 |
ARKW | Buy | ZM | ZOOM VIDEO COMMUNICATIONS INC | 106,537 |
ARKW | Buy | VUZI | VUZIX CORP | 183,465 |
ARKW | Buy | ROKU | ROKU INC | 40,801 |
ARKW | Buy | NNDM | NANO DIMENSION LTD | 986,600 |
ARKW | Buy | MNDY | MONDAY.COM LTD | 45,756 |
ARKW | Buy | HOOD | ROBINHOOD MARKETS INC | 221,389 |
ARKW | Buy | GENI | GENIUS SPORTS LTD | 881,741 |
ARKW | Buy | CND | CONCORD ACQUISITION CORP | 235,842 |
ARKX | Buy | PLTR | PALANTIR TECHNOLOGIES INC | 51,576 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Find a Qualified Financial Advisor (Sponsor)
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.